WHO WE ARE
Mediclinic is an international private healthcare services group, established in South Africa in 1983, with current operating divisions in Switzerland, Southern Africa (South Africa and Namibia) and the United Arab Emirates.
Our core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services.
The Company’s primary listing is on the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia. The Group’s registered office is in London, United Kingdom.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading UK-based private healthcare group listed on the LSE.
Mediclinic is committed to conducting our business with honesty and integrity. Our Code of Business Conduct and Ethics and core values represent the basic beliefs to which we aspire.
- Client orientation
- Team approach
- Mutual trust and respect
- Performance driven
Mediclinic takes a sustainable, long-term approach to business, putting patients at the heart of its operations and consistently delivering high-quality healthcare services. In order to deliver on these priorities, the Group upholds the highest standards of clinical governance and ethical behaviour across its divisions, invests significant time and resources in recruiting and retaining skilled staff, makes considerable investment into its facilities and equipment and respects the communities and environment in the areas in which it operates.
We value diversity and provide equal opportunities for all in the workplace and do not tolerate any form of unfair discrimination.
Mediclinic recognises its accountability to its stakeholders and is committed to effective and regular engagement with them, which is fundamental in maintaining Mediclinic’s corporate reputation as a trusted and respected provider of healthcare services and positioning itself as a leading international private healthcare group. The Group is committed to conducting its business in a manner that respects and promotes the human rights and dignity of all those within our sphere of influence throughout our operations and relationships.
Hirslanden AG, a company registered in Switzerland, is the holding company of the Group’s operating division in Switzerland, trading under the Hirslanden brand. Hirslanden AG is an indirect wholly-owned subsidiary of the Company.
Hirslanden operates 17 acute care private hospitals with 1 805 beds and 4 clinics.
Permanent employees: 9 635
Full-time equivalents: 7 633
For more information, please visit:
Mediclinic Southern Africa (Pty) Ltd, a company registered in South Africa, is the holding company of the Group’s operating division in Southern Africa (South Africa and Namibia), trading under the Mediclinic brand. Mediclinic Southern Africa (Pty) Ltd is an indirect wholly-owned subsidiary of the Company. Most of its operating subsidiary companies have external doctor shareholding.
Mediclinic Southern Africa operates 49 acute care private hospitals and 2 day clinics in South Africa and three hospitals in Namibia, with 8 131 beds in total. Through its wholly-owned subsidiaries, MHR and ER24 it offers related services in healthcare recruitment and emergency transportation services, respectively.
|Permanent employees:||16 068|
|Full-time equivalents:||19 795 (which include
3 792 agency staff)
Mediclinic Middle East operates 6 acute care private hospitals and 22 clinics mainly in Abu Dhabi and Dubai, UAE with 748 beds.
The Group’s operating division in the UAE operates mainly in Dubai and Abu Dhabi, trading under the Mediclinic brand. Emirates Healthcare Holdings Limited BVI, a company registered in the British Virgin Islands, is the intermediary holding company of the division’s operations in Dubai; and Al Noor Golden Commercial LLC, a company registered in the UAE, is the intermediary holding company of the division’s operations in Abu Dhabi.
|Permanent employees:||5 801|
|Full-time equivalents:||5 830|
For more information, please visit:
Refer to the Investments in Subsidiaries, Associates and Joint Ventures annexed to the consolidated annual financial statements for more information on the Group’s ownership structure.